Page last updated: 2024-08-26

n-tert-butylhydroxylamine and Macular Degeneration

n-tert-butylhydroxylamine has been researched along with Macular Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ames, BN; Atamna, H; Killilea, DW; Voloboueva, LA	1

Other Studies

1 other study(ies) available for n-tert-butylhydroxylamine and Macular Degeneration

Article	Year
N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:14 Topics: Aged; Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Hydroxylamines; Iron; Iron Chelating Agents; Iron Overload; Macular Degeneration; Mitochondria; Oxidative Stress; Pigment Epithelium of Eye; Retina	2007

Article

Year

N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:14

Topics: Aged; Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Hydroxylamines; Iron; Iron Chelating Agents; Iron Overload; Macular Degeneration; Mitochondria; Oxidative Stress; Pigment Epithelium of Eye; Retina

2007